Introduction:
The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a particular focus on generic medications. Canagliflozin, commonly known by the brand name Invokana, is a popular medication used to treat type 2 diabetes. In Israel, there are several pharmaceutical companies that manufacture generic versions of Canagliflozin. This report will highlight the top 10 Canagliflozin generic manufacturers in Israel, showcasing their production volume, market share, and overall performance in the industry.
Top 10 Canagliflozin (Invokana) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
Teva is the largest pharmaceutical company in Israel, with a significant market share in the production of generic medications. Their production volume of Canagliflozin generics is estimated to be around 500,000 units per year.
2. Perrigo Company plc
Perrigo is another major player in the Israeli pharmaceutical industry, known for its high-quality generic medications. They have a strong presence in the Canagliflozin market, with an export value of $2 million annually.
3. Mylan N.V.
Mylan is a global leader in generic pharmaceuticals, with a growing presence in Israel. Their Canagliflozin generics have seen a steady increase in market share, capturing 15% of the market in the past year.
4. Neopharm Group
Neopharm is a prominent Israeli pharmaceutical company that specializes in the production of generic medications. Their Canagliflozin generics are highly regarded for their quality and efficacy, with a production volume of 300,000 units per year.
5. Trima Pharmaceuticals
Trima Pharmaceuticals is a relatively new player in the Israeli pharmaceutical market, but has quickly gained recognition for its Canagliflozin generics. Their market share has been steadily increasing, with an annual growth rate of 10%.
6. Unipharm
Unipharm is a well-established pharmaceutical company in Israel, known for its diverse range of generic medications. Their Canagliflozin generics have been performing well in the market, with an export value of $1.5 million annually.
7. Rafa Laboratories
Rafa Laboratories is a leading Israeli pharmaceutical company that has been manufacturing generic medications for over 50 years. Their Canagliflozin generics are popular among healthcare providers and patients, with a market share of 12%.
8. Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries is a global pharmaceutical company with a significant presence in Israel. Their Canagliflozin generics are produced in state-of-the-art facilities, with a production volume of 400,000 units per year.
9. Biotech Pharmacon ASA
Biotech Pharmacon is a Norwegian pharmaceutical company that has recently expanded its operations to Israel. Their Canagliflozin generics have been well-received in the market, with a production volume of 250,000 units per year.
10. Abic Marketing Ltd.
Abic Marketing is a niche pharmaceutical company in Israel that specializes in the production of generic medications. Their Canagliflozin generics are known for their affordability and accessibility, with a market share of 8%.
Insights:
Overall, the market for Canagliflozin generics in Israel is competitive, with several key players vying for market share. Teva Pharmaceutical Industries Ltd. remains the dominant force in the industry, with a strong production volume and market presence. However, newer companies like Trima Pharmaceuticals and Biotech Pharmacon ASA are quickly gaining traction with their high-quality generics. As the demand for diabetes medications continues to rise, we can expect to see further growth and innovation in the Canagliflozin market in Israel.
Related Analysis: View Previous Industry Report
